California Offers a Lifeline for Medical Residents Who Can’t Find Abortion Training

Abortion restrictions in 18 states have curtailed access to training in skills that doctors say are critical for OB-GYN specialists and others. A new California law makes it easier for out-of-state doctors to get experience in reproductive medicine.

Will CMS Crack Down on Prior Authorization?

There’s the Idaho doctor whose infant daughter developed a brain tumor. A woman in Southern California who waited months for an MRI before dying in the hospital. And a North Carolina patient who has trigeminal neuralgia — a condition so painful it’s commonly called the “suicide disease.” They all have something in common, aside from […]

These Patients Had to Lobby for Correct Diabetes Diagnoses. Was Their Race a Reason?

Adults who develop one autoimmune form of diabetes are often misdiagnosed with Type 2 diabetes. Those wrong diagnoses make it harder to get the appropriate medications and technology to manage their blood sugar. Many Black patients wonder if their race plays a role.

Patients With Narcolepsy Face a Dual Nightmare of Medication Shortages and Stigma

It’s been more than a year since the FDA declared a national shortage of Adderall, and it’s affecting more than just patients with ADHD. Those with narcolepsy, a much rarer condition, are often treated with the same medication. Without it, they’re often unable to drive or function as usual.

Mental Health Courts Can Struggle to Fulfill Decades-Old Promise

Mental health courts have been touted as a means to help reduce the flow of people with mental illness into jails and prisons. But the specialized diversion programs can struggle to live up to that promise, and some say they’re a bad investment.

‘AGGA’ Inventor Testifies His Dental Device Was Not Meant for TMJ or Sleep Apnea

The FDA and Department of Justice are investigating the Anterior Growth Guidance Appliance, or “AGGA.” TMJ and sleep apnea patients have filed lawsuits alleging the device harmed them. Its inventor now says the AGGA was never meant for these ailments.

The Year in Opioid Settlements: 5 Things You Need to Know

In the past year, opioid settlement money has gone from an emerging funding stream for which people had lofty but uncertain aspirations to a coveted pot of billions being invested in remediation efforts. Here are some important and evolving factors to watch going forward.

‘I Am Just Waiting to Die’: Social Security Clawbacks Drive Some Into Homelessness

The Social Security Administration is reclaiming billions of dollars in alleged overpayments from some of the nation’s poorest and most vulnerable, leaving some people homeless or struggling to stay in housing, beneficiaries and advocates say.

‘They See a Cash Cow’: Corporations Could Consume $50 Billion of Opioid Settlements

As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?

As Foundation for ‘Excited Delirium’ Diagnosis Cracks, Fallout Spreads

Major policy changes and disavowals have made this a watershed year for curbing the use of the discredited “excited delirium” diagnosis to explain deaths in police custody. Now the ripple effects are spreading across the country into court cases, state legislation, and police training classes.